Futures pause with job data on deck 📈

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Wednesday, October 4th. I hope you have a great day in the market. Now, let's get ready to trade! Markets 📈 Stocks sold off on Tuesday, with the Nasdaq's 1.8% decline leading the charge lower. The S&P 500 lost 1.3%, and the Dow fell 1.2%. The Russell 2K's 1.6% loss was in line with the large-cap indexes. Today, futures are holding onto slim gains in early trading. S&P 500 contracts are up by less than 0.1%. Sponsored [Shark Tank's Kevin O'Leary is Putting His Money Here]( If you've ever watched Shark Tank, you know Kevin O'Leary - AKA Mr. Wonderful - is very protective of his money. In fact, he expects to multiply his investments by at least 10x when he gets in... The company featured here is exactly what Mr. Wonderful looks for. In fact, not only did Kevin invest his money in it, he also put his own personal team to work in the company. This opportunity could be part of "the greatest wealth transfer in history," so make your move before you miss out. [Get all the Details HERE >>]( Premarket Highlights 🔎 ⚪ None No major market-moving news to report this morning. What to Watch Today 👀 More Job Data Today's docket features the ADP jobs report, which will update investors on the private-sector hiring market's progress in September. Economists are looking for a top-line number of 150,000 jobs created, down from 177,000 a month earlier. This report will be a warm-up to the upcoming September Jobs Report, which is set for release on Friday. Major Earnings 💰 RPM International Inc. [RPM] ... AM Acuity Brands, Inc. [AYI] ... AM Helen Of Troy Limited [HELE] ... AM Accolade, Inc. [ACCD] ... AM Angiodynamics, Inc. [ANGO] ... AM Resources Connection, Inc. [RGP] ... PM Economy 🏗\ - ADP employment [Sep] ... 8:15a - S&P final U.S. services PMI [Sep] ... 9:45a - Factory orders [Aug] ... 10:00a - ISM services [Sep] ... 10:00a Running Hot 🔥 Gainers - Senti Biosciences [SNTI] >> +19.2% - Conduit Pharmaceuticals [CDT] >> +19.3% - Brainstorm Cell Therapeutics [BCLI] >> +33.0% - Comera Life Sciences [CMRA] >> +19.2% Decliners - Viq Solutions [VQS] >> (22.5%) - Femasys [FEMY] >> (25.3%) - Kineta [KA] >> (24.0%) - Eastside Distilling [EAST] >> (14.6%) Freeline Therapeutics [FRLN] - Last Close: $3.76 Freeline Therapeutics just unveiled a promising bit of clinical data. Early today, the biotech reported positive clinical data from the first cohort of a Phase 1/2 HALILEO-1 trial of FLT201 in Gaucher disease. The data showed the drug produced a 700-fold baseline increase in plasma enzyme activity in the first two trial participants who received it. Freeline said the drug also produced a favorable safety and tolerability profile, with no infusion reactions or serious adverse events as of 13 weeks of dosing. Freeline CEO Michael Parini said the company is "committed to expeditiously advancing FLT201." FRLN is one of today's top stocks with a 45.4% gain on active trading volume. My Take: FRLN might be onto something here. The chart is also flashing some favorable signals. You might want to put this one on your radar. Edgewise Therapeutics [EWTX] - Last Close: $5.82 A recent clinical update is rallying Edgewise Therapeutics. The biopharma firm presented new data on EDG-5506 for Becker Muscular Dystrophy at an industry conference yesterday. Edgewise hosted a symposium at the 28th International Annual Congress of the World Muscle Society at 4:30 p.m. on Tuesday. The presentation went over Edgewise's open label study as a treatment for Beck Muscular Dystrophy, and it's getting a warm reception from the market. Specific details of the presentation aren't available at the time of writing, but shares are heating up quickly, which likely signals the data was promising. EWTX is up 17.5% in early premarket trading. My Take: EWTX may have a promising treatment on its hand, but it's hard to read into it without having more specific info. This is a developing story, so I'm sure we'll hear more soon. Vivos Therapeutics [VVOS] - Last Close: $0.1850 A new partnership is boosting shares of Vivos Therapeutics. This morning, the company announced strategic agreements with Ormco and On Demand Orthodontist to supply its Spark clear aligners. Under the terms of the deal, the company will team up with Ormco for joint marketing and sales, with support from both brands' field sales team. On the other hand, On Demand Orthodontist will supply its network of providers with access to the Spark aligners. Financial terms of the deals weren't disclosed, but shares of VVOS are leading the premarket with a 65.4% gain on the news. My Take: This is a tough one. Very tiny stock with a very niche market. It's a long-shot, but it could have speculative potential. Sonendo [SONX] - Last Close: $0.32 Sonendo is rebounding after a pullback. The micro-cap dental equipment stock suffered a steep pullback on Tuesday after it announced it received a non-compliance notice from NYSE. Shares of SONX lost 55.6% on Tuesday following the report of the company's non-compliance with NYSE's $1 minimum share price rule. Sonendo has six months to remedy the situation, and it says it intends to respond within 10 business days of its receipt of the notice. SONX is rebounding with a 28.9% gain in today's premarket. My Take: SONX is in a tough spot. I would want to see more signs of progress before I made a move here. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](